Lacosamide Tablet, Film Coated
Product Images NDC 62332-173

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 62332-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Lacosamide 100 mg)

Each tablet of this medicine contains 100mg of Lacosamide, USP. The usual dosage information can be found in the package insert. The permitted storage temperature is between 15°C to 30°C. The manufacturing company is Alembic Pharmaceuticals Limited and the tablets are manufactured for prescription use only. The package information includes the NDC number and GTIN. There is also a coding area to identify the product.*

FDA Label Image

30 Tablets (Lacosamide 150 mg)

FDA Label Image

30 Tablets (Lacosamide 200 mg)

Each tablet of this medication contains 200 mg of Lacosamide, USP. The usual dosage information is available in the package insert. The storage temperature range is between 20-25°C (68-77°F), and excursions are permitted between 15-30°C (59-86°F). The medication comes in child-resistant packaging and is manufactured by Alembic Pharmaceuticals Limited. The accompanying Medication Guide must be provided to each patient, and the guide is available by calling a specific number. This medication has a unique identification number, and the medication guide is available upon request.*

FDA Label Image

30 Tablets (Lacosamide 50 mg)

Exh i counttel ot NDC 62332-171-30 is a package containing Lacosamide tablets manufactured by Alembic Pharmaceuticals. The product should be stored between 15° and 30°C (59° to 86°F) and protected from moisture. The package contains 30 tablets and the manufacturer's address is in Bedrse, NJ.*

FDA Label Image

Figure1 (Lacosamide Figure 1)

FDA Label Image

Figure2 (Lacosamide Figure 2)

The given text is a table showing the "Responder Rate" (percentage of patients who showed improvement) for a medication called "Lacosamide" and the placebo groups in three studies (2, 3, and 4). The medication was administered at 200mg/day, 400mg/day, and 600mg/day. The table also shows the proportion of patients who had worsened. There are no other details available in the text.*

FDA Label Image

Structure (Lacosamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.